Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

doi:10.1016/j.ijantimicag.2015.01.006

. 2015 May;45(5):557-9.

doi: 10.1016/j.ijantimicag.201501006. Epub 2015 Feb 16.

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Natnaree Saiprom ¹, Premjit Amornchai ², Vanaporn Wuthiekanun ², Nicholas P J Day ³, Direk Limmathurotsakul ⁴, Sharon J Peacock ⁵, Narisara Chantratita ⁶

Affiliations

¹ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
² Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
³ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
⁴ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Tropical Medicine and Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
⁵ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, UK.
⁶ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: narisara@tropmedres.ac.

PMID: 25758020
PMCID: PMC4537509
DOI: 10.1016/j.ijantimicag.201501006

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Natnaree Saiprom et al. Int J Antimicrob Agents. 2015 May.

. 2015 May;45(5):557-9.

doi: 10.1016/j.ijantimicag.201501006. Epub 2015 Feb 16.

Authors

Natnaree Saiprom ¹, Premjit Amornchai ², Vanaporn Wuthiekanun ², Nicholas P J Day ³, Direk Limmathurotsakul ⁴, Sharon J Peacock ⁵, Narisara Chantratita ⁶

Affiliations

¹ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
² Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
³ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
⁴ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Tropical Medicine and Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
⁵ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, UK.
⁶ Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: narisara@tropmedres.ac.

PMID: 25758020
PMCID: PMC4537509
DOI: 10.1016/j.ijantimicag.201501006

No abstract available

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Trimethoprim/sulfamethoxazole minimum inhibitory concentrations (MICs) for Burkholderia pseudomallei from 3038 patients with primary melioidosis presenting to a hospital in northeast Thailand between 2004 and 2012. MICs were determined using the Etest. The numbers above each column represent the number of isolates with the corresponding MIC. The table shows the total and annual number of B. pseudomallei isolates tested, the MIC₅₀ (concentration that inhibits 50% of bacterial isolates) and the percentage resistant.

See this image and copyright information in PMC

References

1. Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed
1. Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P. Trimethoprim–sulfamethoxazole versus trimethoprim–sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807–814. - PMC - PubMed
1. Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031. - PubMed
1. Dance D.A., Davong V., Soeng S., Phetsouvanh R., Newton P.N., Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368–369. - PMC - PubMed
1. Clinical and Laboratory Standards Institute . CLSI; Wayne, PA: 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline—second edition. Document M45-A2.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

087769/Z/08/Z/Wellcome Trust/United Kingdom

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed

[2] Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed

[3] Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P. Trimethoprim–sulfamethoxazole versus trimethoprim–sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807–814. - PMC - PubMed

[4] Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P. Trimethoprim–sulfamethoxazole versus trimethoprim–sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807–814. - PMC - PubMed

[5] Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031. - PubMed

[6] Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031. - PubMed

[7] Dance D.A., Davong V., Soeng S., Phetsouvanh R., Newton P.N., Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368–369. - PMC - PubMed

[8] Dance D.A., Davong V., Soeng S., Phetsouvanh R., Newton P.N., Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368–369. - PMC - PubMed

[9] Clinical and Laboratory Standards Institute . CLSI; Wayne, PA: 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline—second edition. Document M45-A2.

[10] Clinical and Laboratory Standards Institute . CLSI; Wayne, PA: 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline—second edition. Document M45-A2.

Account

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Affiliations

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Authors

Affiliations

Figures

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical